NOVEXATIN
Sun Pharma gains as subsidiary Taro inks drug pactElara Capital is of the view that current valuations of the company are rich and has maintained its ‘accumulate’ rating with target price o...
Coming soon: Novo Nordisk’s long-lasting insulin injectionNovo is betting big on Tresiba in the emerging markets after it failed to get an approval for the drug from the US Food and Drug Administra...
- Load More